Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in Feb-March
Hyderabad: Bharat Biotech has already got emergency use authorisation of Covaxin from the Drug Controller General of India (DCGI). Now Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during February-March this year. Besides Covaxin, the...











































